The European Medicines Agency (EMA) on the grounds of negligence has approved remdesivir as a treatment for Covid-19. A decision potentially has several billion euros on a scientific basis more than questionable if not distorted. The study, pivotal to the recommendation for remdesivir, published in… – Lire la suite sur FranceSoir.fr
FranceSoir
– Remdesivir for a few billion more » from Gilead with the European Medicines Agency?
Source: Lire l'article complet de France-Soir
